You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
睿智醫藥(300149.SZ):CEO華風茂所控制的金策投資增持股票收益權385.67萬股
格隆匯 07-20 20:59

格隆匯7月20日丨睿智醫藥(300149.SZ)公吿,公司於2021年7月20日收到公司CEO華風茂和控股股東雲南八本健康產業有限公司(簡稱“八本健康”)的通知,華風茂基於對公司未來發展的信心,以其控制的CHINA FINANCE STRATEGIES INVESTMENT DB LIMITED(簡稱“金策投資”)指令中國國際金融股份有限公司的香港子公司CICC Wealth Investment Limited(簡稱“中金香港”),於2021年7月20日通過證券交易所大宗交易受讓公司控股股東八本健康持有的公司股份385.67萬股,佔公司總股本的0.77%。

本次增持方式為收益互換合約。在收益互換合約中,華風茂控制的金策投資以足額的現金保證金轉入中金香港,中金香港再通過其資管專户買入股票,該股票收益權歸金策投資所有。

因此,華風茂以其控制的金策投資以收益互換的形式持有公司385.67萬股股票收益權,佔公司總股本的0.77%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account